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The present paper describes Danish research activities on porcine reproductive and 
respiratory syndrome (PRRS) with emphasis on experimental infections in pregnant swine. 
The first case of PRRS was diagnosed in Denmark in 1992 and subsequently the disease 
spread to most other parts of the country. The first animal experiments elucidated the 
pathogenicity of Danish PRRS virus (PRRSV) isolates in pregnant sows together with the 
effects of infection at various stages of gestation. In 1996, the introduction of a vaccination 
program using an attenuated live PRRS vaccine led to an epidemic of American type PRRSV 
in the previously unaffected Danish pig population. Acute PRRS like disease was observed in 
non-vaccinated as well as in vaccinated herds, and it was demonstrated that the vaccine strain 
had reverted to virulence. By experimental infection of late term pregnant sows, we 
demonstrated that a field isolate of PRRS vaccine-derived virus (VDV) could cause disease 
in swine consistent with PRRS, thus confirming the etiological role of VDV. Since the 
complex pathology following in utero infection with PRRSV indicates impairment of the 
immune system of congenitally infected pigs, we studied various aspect of the host defence in 
piglets surviving transplacental infection with PRRSV. Leukocyte subpopulations in 
peripheral blood and bronchoalveolar fluid (BALF) were modulated, viability of lung 
macrophages was reduced, phagocytosis against Salmonella in blood monocytes as well as 
oxidative burst capacity of alveolar macrophages was inhibited, there was an over-expression 
of cytokine IL-10 in BALF cells, and ciliary disruption in the airways was observed. 
Altogether, our findings supported the hypothesis of the existence of immunosuppression in 
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Porcine reproductive and respiratory syndrome (PRRS) is a severe disease in pigs 
characterized by reproductive failure in sows and gilts, increased preweaning mortality and 
pneumonia in growing pigs. The syndrome was initially observed in the USA in 1987 (1). In 
1990, similar clinical outbreaks were reported in Germany (2) with further spread throughout 
Europe in the following years (3,4). The causal agent of the disease is a positive-strand 
enveloped RNA virus (5) designated PRRS virus (PRRSV), which primarily replicates in 
macrophages. The clinical signs of PRRS vary widely. Already early after the appearance of 
the disease, these variations were suggested to be the result of a range of modifying factors, 
e.g. animal age, differences in genetic susceptibility, environmental factors including sanitary 
status of pigs at the time of infection, management, immune status, virus strain differences 
(6-9). 
PRRSV isolates are divided into two main genotypes: European type PRRSV and North 
American type PRRSV, representing Type I and Type II, respectively (10,11). Initially, the 
European strains were only isolated in Europe and the American strains in the US and 
Canada but now they are mixed 
During 2 decades, PRRS has constituted an economically significant viral disease in most 
major pig-producing areas throughout the world. In spite of the fact that tremendous efforts 
have been initiated to combat the disease, there is still a lack of crucial knowledge of disease 
mechanisms in PRRS, thus hampering the possibilities of effectively controlling this disease. 
Thus, more than 20 years after the appearance of the disease, PRRSV still continues to be an 
important threat for the pig industry.  
In Denmark, the first case of PRRS was diagnosed in 1992 (12). Subsequently, the disease 
spread to most other parts of the country and became a major challenge to the Danish swine 
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population with considerable implications for animal welfare and economical sustainability. 
This paper will present some of the various research activities initiated at our institute to 
contribute to the international battle against the disease. However, since major efforts have 
related to PRRS in pregnant sows, this review will primarily describe work on experimental 
transplacental infections. 
 Animal experiments with PRRSV –European type 
The appearance of PRRS in Germany and in the Netherlands in the winter of 1990 - 1991 and 
the further spread through Western Europe during 1991 made clear the risk of introduction of 
the disease to Denmark. The identification of the etiologic agent as PRRSV paved the way 
for the development of diagnostic procedures to confirm the disease. By the end of 1991, 
virological and serological analyses had been established in our laboratory. In March 1992, 
the first case of PRRS in Denmark was diagnosed by the detection of specific antibodies 
against PRRSV in serum samples from a sow herd in the Southern part of Denmark, close to 
the German border. Subsequently, European type PRRSV with only minor antigenic 
differences to a Dutch isolate, Lelystad Virus (5), was isolated from a sow farrow to finish 
herd with clinical signs consistent with PRRS. In order to test the pathogenicity of the isolate, 
we carried out an animal experiment in pregnant dams (12). Transplacental infection was 
demonstrated but neither significant reproductive disorders nor marked clinical signs were 
observed. This was in contrast to the typical signs of PRRS demonstrated in previous studies 
(13-16). The result of our experiment was speculated to reflect that this early isolated Danish 
strain was of a lower virulence. However, substantial evidence of the variety of factors 
affecting the clinical outcome of PRRSV infection leaves the explanation open.  
Early observations revealed that exposure of pregnant sows and gilts to PRRSV in the last 
trimester typically results in reproductive failure and increased preweaning mortality under 
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field as well as experimental conditions (5,14-16). Only few studies focused on the 
reproduction of the disease at earlier stages of gestation (17-20) and they did not elucidate 
putative consequences of intrauterine infection on perinatal disease and mortality of pigs. 
Therefore, we initiated an experiment to study the effect of PRRSV infection at various 
stages of gestation (21). The demonstration of transplacental infection of PRRSV in 6 out of 
8 litters inoculated on day 72 of gestation or later but not at earlier stages of gestation 
supported the hypothesis that PRRSV infections late in pregnancy had the greatest likelihood 
of transplacental infection of fetuses, as previously described (5,14-16). Pronounced 
reproductive disorders with high numbers of stillborn pigs together with high piglet mortality 
during an observation period of 2 weeks were observed for dams inoculated around 85 days 
of gestation and - although less pronounced - for dams inoculated at 72 day of gestation. The 
above findings together with the histopathological demonstration of PRRS typical focal non-
suppurative inflammatoric conditions in the lung occasionally associated with hyperplastic 
lymphadenopathy (7,20) provided a valuable contribution to the knowledge of the importance 
of stage of pregnancy for the outcome of infection. 
Problems associated with the introduction of vaccination of Danish pigs with an 
attenuated live PRRS vaccine 
Around 1995, the herd prevalence of PRRS in finishing pigs in Denmark was 33% (22). In 
order to prevent or at least reduce further spread of the disease in the Danish pig population, a 
voluntary PRRS control program was started early 1996. One of the objectives of the 
program was to define the PRRS serological status of all swine herds followed by vaccination 
of 3- to 18-week-old piglets in seropositive herds using the attenuated live “Ingelvac®  PRRS 
MLV” vaccine (Boehringer Ingelheim Animal Health, MO, USA).  Furthermore, all boars 
entering the artificial insemination centres had been vaccinated with the vaccine since 
October 1995. Based on the examination of more than 2000 sow sera originating from all 
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regions in Denmark, the serological screening, using the immunoperoxidase monolayer assay 
(IPMA) carried out as a double test with a Danish strain of PRRSV and the PRRS vaccine 
virus (23), did not indicate the occurrence of vaccine/American PRRSV strains in Denmark at 
that time (24). The PRRS vaccination was carried out almost simultaneously in more than 
1000 herds, many of which had no clinical symptoms and displayed a serological herd profile 
indicating that PRRSV did not circulate among sows and nursing piglets.  
Two to 3 months after the implementation of the vaccination program, acute PRRS-like 
problems continuously developed in about 500 herds (25). At the same time, a sudden 
increase in the number of samples (fetuses, weakborn and stillborn piglets) submitted to our 
laboratory for PRRS examination was observed. In the vast majority of the herds, the 
appearance of the clinical problems coincided with the recent vaccination using “Ingelvac®  
PRRS MLV”, which is based on the pathogenic American PRRSV field isolate VR-2332 
(26). American type PRRSV, identified as vaccine-derived virus (VDV) by the use of 
monoclonal antibodies, RT-PCR and nucleotide sequencing,  was isolated from more than 
100 of the herds (25).  This was the first time American type PRRSV was isolated from 
clinical cases in Denmark, and the outbreak of acute PRRS was epidemiologically closely 
linked to the use of the live vaccine (27,28), and linked to reversion of the vaccine virus to a 
pathogenic phenotype (25,29), which again was proven to be a direct derivative of the live 
attenuated vaccine virus (30). In order to confirm the etiological role of PRRSV-VDV for the 
clinical outbreaks, we studied the pathogenicity of one of the field isolates by experimental 
infection of late term pregnant sows (31). 
Intranasal inoculation of PRRS-naïve sows with the PRRSV-VDV isolate in the last trimester 
resulted in congenital infection, fetal death and increased preweaning mortality.  The 
reproductive signs and losses, the gross lesions in the fetuses, and the generally unhealthy 
appearance of many of the live-born pigs were comparable with previous observations, and 
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the interstitial pneumonia demonstrated in the vast majority of the infected piglets were 
compatible with lesions typical for PRRS (7,13-16,20,21,32). As such, the present study 
showed that vaccine-derived PRRSV can cause disease in swine consistent with PRRS. 
The attenuated vaccine was widely used in a number of other countries, apparently without 
displaying any problems. Since, at that time, PRRS vaccine problems were only reported to 
occur in Denmark, parts of the scientific community initially considered the interpretation of 
our results as controversial. As an explanation of the Danish situation, however, we suggested 
that a number of unique circumstances existed regarding the use of the live vaccine in 
Denmark, e.g. the use of serologic tests which enabled distinction between infection with 
European and American strains of PRRSV (31). Altogether, the situation in Denmark made it 
very simple to observe vaccine reversion, which might go unnoticed in other countries, and 
later studies have also supported vaccine reversion as the cause of clinical problems (33-35). 
In utero infection with PRRSV affects immune functions of surviving piglets 
It is well known that piglets congenitally infected with PRRSV can be viremic at birth 
(12,21,31), and that preweaning mortality due to secondary infections often increases during 
outbreaks of PRRS (36-38).  An underlying mechanism for increased susceptibility to other 
pathogens following PRRSV infection could be suppression of the immune system in 
infected pigs as a result of interaction between PRRSV and the immune system. The majority 
of studies dealing with the influence of PRRSV on immune functions of the pig were carried 
out either in vitro or in vivo using young pigs infected at various ages (39) and the 
experimental evidence for any interaction of PRRSV with other pathogens was ambiguous. 
Thus, we infected more than 100 young piglets with European type PRRSV without seeing 
neither clinical signs nor significant immunological changes (40), - and this observation 
challenged our view of angle. 
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 In 2001, Feng et al. (41) suggested an immunosuppressive effect of in utero infection with 
PRRSV. Since the hypothesis was supported by our own observations (31), we carried out a 
number of experiments to elucidate the interaction of PRRSV with various immune 
mechanisms in piglets surviving transplacental infection (39,42-45). After inoculation with 
PRRSV on day 90 of gestation, two sows delivered 23 liveborn, congenitally infected pigs, 
which were examined over a period of 6 weeks after birth (39). The significantly increased 
postnatal levels of cells with CD2, CD3 and CD8 phenotypes in peripheral blood and 
broncho-alveolar lavage fluid (BALF) indicated that in utero infection causes a long lasting 
activation of the immune system. Furthermore, our results supported the hypothesis that 
CD8+ cells play a role in the control of PRRSV replication (46,47,48), as also indicated by 
the detection of cytotoxic T lymphocytes close to PRRSV infected macrophages in the lungs 
of infected pigs (45). The cytokine profiles for peripheral blood mononuclear cells and lymph 
node cells showing increased levels of Il-4, TNF-α and IFNγ in infected pigs up to 6 weeks 
after birth (42) are believed to reflect a general lymphocyte activation stage supporting the 
assumption of a prolonged activation of immune mechanisms after in utero infection, as also 
suggested above. The detection of PRRSV in BALF cells (especially macrophages) of 
infected pigs for a period up to 6 weeks after birth, when virus could no longer be detected in 
blood (39), indicated functional alterations of these cells. In addition, the occurrence of 
immunomodulatory events could also be confirmed by the detection of increased levels of 
cytokine (TNF-α, Il-10, IL-12, IL-8 and IFNγ) expression in BALF cells obtained from 2- 
and 4-week-old infected piglets (43). As also later demonstrated in a substantial number of 
reports (49-51), our study suggested an important role for a number of cytokines, e.g. TNF-α, 
Il-10, and IFNγ, in the immune response to PRRSV. However, further studies are required to 
enlighten the complicated cytokine puzzle during PRRSV infection. 
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None of the findings described above provided unequivocal support of the existence of 
immunosuppression after in utero infection. However, it has been observed that pigs 
surviving congenital PRRSV infection can exhibit the severest form of respiratory disease 
with mortality sometimes reaching 100% within 3 weeks after birth (41,52,53).  The complex 
pathology following in utero infection with PRRSV is described to represent a unique form of 
the disease referred to as congenital PRRS (54). This is in accordance with our findings that 
i) intrauterine infection with PRRSV resulted in high preweaning mortality of liveborn piglets 
associated with severe pathological lesions characterized by varying levels of pneumonia, 
including severe pleuritis and necrotizing  pneumonia, pericarditis, enteritis and multiple 
abscesses (31), and that ii) pigs congenitally infected with PRRSV were significantly more 
susceptible to infection with Salmonella Typhimurium at 4 weeks of age than non-infected 
control pigs (55). Altogether, these observations indicated that the hypothesis of the existence 
of PRRSV induced suppression of the host immune defence in pigs congenitally infected 
with PRRSV should be sustained. This was as also supported by our demonstration  of 
decreased phagocytic activity (56) and reduction (57) of the total number of alveolar lung 
macrophages after PRRSV infection in vivo and in vitro, respectively, reduced viability of 
lung macrophages in 2-week-old congenitally infected piglets (39), inhibition of phagocytosis 
against Salmonella in blood monocytes as well as oxidative burst capacity of alveolar 
macrophages (44), over-expression of the immunosuppressive cytokine IL-10 in BALF cells 
(43), and ciliary disruption in the bronchi (Figure 1) after intrauterine infection with PRRSV. 
Altogether, these findings indicate impairment of the host defence in congenitally PRRSV 
infected pigs. In particular, the reduced capacity of alveolar lung macrophages to ingest and 
kill bacteria combined with the hampered mucociliary clearance mechanisms, caused by the 
disruption of cilia in the airways, is likely to play an important role in the pathogenesis of 








Figure 1: Destruction and loss of bronchial cilia in a pig 
congenitally infected with PRRSV (A). Normal structure and 
numbers of cilia are present in an age-matched non-infected 
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